Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

67%

4 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

4(80.0%)

N/A

1(20.0%)

5Total

Phase 4(4)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT01030666Phase 4Terminated

Effect of Postsurgical Systemic Doxycycline After Regenerative Periodontal Therapy

Role: collaborator

NCT01329731Phase 4Completed

Remineralisation of White Spot Lesions by Elmex® gelée in Post-orthodontic Patients

Role: lead

NCT01747226Not ApplicableUnknown

Effect of Mouth Rinses in Oral Malodor

Role: collaborator

NCT01226251Unknown

New "in Vitro" Diagnostic Test for Oral Malodour

Role: collaborator

NCT01317446Phase 4Completed

Effect of Mouthrinsing on Inflammation of the Gums.

Role: collaborator

NCT00268138Phase 4Unknown

Elmex Gel Efficacy in Preventing White Spot Lesions

Role: collaborator

All 6 trials loaded